Trial Profile
Impact of CYP genetic polymorphism on clinical events after percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) : An ancillary study of the Japanese CTO PCI Expert Registry
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2014
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Peripheral arterial occlusive disorders
- Focus Adverse reactions; Pharmacogenomic
- 25 Aug 2014 New trial record